Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Stuehler

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Journal of Infectious Diseases|November 26, 2015
Reply to Fernández-Ruiz et alClaudia Stuehler, Nina Khanna
Methods in Molecular Biology (Clifton, N.J.)|June 7, 2017
T-Cell-Mediated Cross-Protective ImmunityNina Khanna, Claudia Stuehler
Current Opinion in Infectious Diseases|July 18, 2022
Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipientsCarla S Walti, Claudia Stuehler, Darya Palianina, et al.
Cell Reports|October 7, 2020
Interferon-λ Enhances the Differentiation of Naive B Cells into Plasmablasts via the mTORC1 PathwayMohammedyaseen Syedbasha, Ferdinando Bonfiglio, Janina Linnik, et al.
Swiss Medical Weekly|September 23, 2016
Host response to fungal infections - how immunology and host genetics could help to identify and treat patients at riskNina Khanna, Claudia Stuehler, Anna Lünemann, et al.
The Journal of Infectious Diseases|November 5, 2014
Multispecific Aspergillus T cells selected by CD137 or CD154 induce protective immune responses against the most relevant mold infectionsClaudia Stuehler, Justyna Nowakowska, Claudia Bernardini, et al.
Blood|June 7, 2011
Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154Nina Khanna, Claudia Stuehler, Barbara Conrad, et al.
Cytotherapy|August 16, 2015
T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cellsJustyna Nowakowska, Claudia Stuehler, Adrian Egli, et al.
Blood|August 7, 2009
Selective depletion of alloreactive T cells by targeted therapy of heat shock protein 90: a novel strategy for control of graft-versus-host diseaseClaudia Stuehler, Stephan Mielke, Manik Chatterjee, et al.
Journal of Leukocyte Biology|August 13, 2015
Combined PI3K/Akt and Hsp90 targeting synergistically suppresses essential functions of alloreactive T cells and increases TregsCarsten Berges, Tanja Bedke, Claudia Stuehler, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Journal of Infectious Diseases|November 26, 2015
Reply to Fernández-Ruiz et alClaudia Stuehler, Nina Khanna
Methods in Molecular Biology (Clifton, N.J.)|June 7, 2017
T-Cell-Mediated Cross-Protective ImmunityNina Khanna, Claudia Stuehler
Current Opinion in Infectious Diseases|July 18, 2022
Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipientsCarla S Walti, Claudia Stuehler, Darya Palianina, et al.
Cell Reports|October 7, 2020
Interferon-λ Enhances the Differentiation of Naive B Cells into Plasmablasts via the mTORC1 PathwayMohammedyaseen Syedbasha, Ferdinando Bonfiglio, Janina Linnik, et al.
Swiss Medical Weekly|September 23, 2016
Host response to fungal infections - how immunology and host genetics could help to identify and treat patients at riskNina Khanna, Claudia Stuehler, Anna Lünemann, et al.
The Journal of Infectious Diseases|November 5, 2014
Multispecific Aspergillus T cells selected by CD137 or CD154 induce protective immune responses against the most relevant mold infectionsClaudia Stuehler, Justyna Nowakowska, Claudia Bernardini, et al.
Blood|June 7, 2011
Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154Nina Khanna, Claudia Stuehler, Barbara Conrad, et al.
Cytotherapy|August 16, 2015
T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cellsJustyna Nowakowska, Claudia Stuehler, Adrian Egli, et al.
Blood|August 7, 2009
Selective depletion of alloreactive T cells by targeted therapy of heat shock protein 90: a novel strategy for control of graft-versus-host diseaseClaudia Stuehler, Stephan Mielke, Manik Chatterjee, et al.
Journal of Leukocyte Biology|August 13, 2015
Combined PI3K/Akt and Hsp90 targeting synergistically suppresses essential functions of alloreactive T cells and increases TregsCarsten Berges, Tanja Bedke, Claudia Stuehler, et al.
Pageof 2